Ade, LLC Merck & Co., Inc. Transaction History

Ade, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $88,398 - $110,730	-1,223 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$71.68 - $78.83 $53,401 - $58,728	-745 Reduced 37.86%	1,223 $92,000
Q2 2021 Jul 27, 2021	BUY	$70.31 - $77.77 $7,031 - $7,777	100 Added 5.35%	1,968 $153,000
Q1 2021 Apr 16, 2021	SELL	$68.86 - $81.11 $44,414 - $52,315	-645 Reduced 25.67%	1,868 $144,000
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $180,358 - $200,160	2,513 New	2,513 $206,000

3,826

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $278B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Ade, LLC, based on Form 13F filings with the SEC.

Stay updated on Ade, LLC with notifications on news.